P-209: High response rates with IMiD retreatment post anti-CD38 exposure in patients with Multiple Myeloma

Ioannis Ntanasis‐Stathopoulos; Maria Gavriatopoulou; Panagiotis Malandrakis; Despina Fotiou; Magdalini Migkou; Nikolaos Kanellias; Evangelos Eleutherakis‐Papaiakovou; Foteini Theodorakakou; Μαρία Ρούσσου; Evangelos Terpos; Efstathios Kastritis; Meletios A Dimopoulos

doi:10.1016/s2152-2650(21)02336-3

Related publications

Article2020

IMiD Retreatment in Patients Refractory to Both an IMiD and an Anti-CD38 Antibody Induces Significant Response Rates Post Anti-CD38 Exposure

Maria Gavriatopoulou, Ioannis Ntanasis‐Stathopoulos, Panagiotis Malandrakis, Despina Fotiou, Magdalini Migkou, Nikolaos Kanellias, Evangelos Eleutherakis‐Papaiakovou, Ioanna Dialoupi, Foteini Theodorakakou, Μαρία Ρούσσου, Evangelos Terpos, Efstathios Kastritis, Meletios A Dimopoulos

Article2021

P-127: Patients with Multiple Myeloma on treatment with Anti-CD38 or Anti-BCMA agents have a suboptimal humoral response following COVID-19 vaccination

Evangelos Terpos, Maria Gavriatopoulou, Ioannis Ntanasis‐Stathopoulos, Αlexandros Briasoulis, Sentiljana Gumeni, Panagiotis Malandrakis, Despina Fotiou, Eleni‐Dimitra Papanagnou, Magdalini Migkou, Foteini Theodorakakou, Μαρία Ρούσσου, Evangelos Eleutherakis‐Papaiakovou, Nikolaos Kanellias, Ioannis P. Trougakos, Efstathios Kastritis, Meletios A Dimopoulos

Article2022

Management and Outcomes of Anti-CD38 Refractory Myeloma Patients: The Impact of Retreatment and of Subsequent Therapies

Efstathios Kastritis, Foteini Theodorakakou, Ioannis Ntanasis‐Stathopoulos, Vasiliki Spiliopoulou, Eirini Solia, Panagiotis Malandrakis, Rodanthi Syrigou, Nikoletta‐Aikaterini Kokkali, Magdalini Migkou, Evangelos Eleutherakis Papaiakovou, Despina Fotiou, Μαρία Ρούσσου, Nikolaos Kanellias, Maria Gavriatopoulou, Evangelos Terpos, Meletios A Dimopoulos

Article2016

Population Pharmacokinetics and Exposure–Response Relationship of Carfilzomib in Patients With Multiple Myeloma

Ying Ou, Sameer Doshi, Anh H. Nguyen, Fredrik Jönsson, Sanjay Aggarwal, Kanya Rajangam, Meletios A Dimopoulos, A. Keith Stewart, Ashraf Badros, Kyriakos P. Papadopoulos, David S. Siegel, Sundar Jagannath, Ravi Vij, Rubén Niesvizky, Richard Graham, Jenn Visich

Article2023

Management and Outcomes of Anti-CD38 Refractory Patients: The Impact of Retreatment and of Subsequent Therapies

Efstathios Kastritis, Foteini Theodorakakou, Ioannis Ntanasis-Stathopoulos, Vassiliki Spiliopoulou, Eirini Solia, Panagiotis Malandrakis, Rodanthi Syrigou, Nikoleta Kokkali, Magdalini Migkou, Evangelos Eleutherakis‐Papaiakovou, Despina Fotiou, Μαρία Ρούσσου, Nikolaos Kanellias, Maria Gavriatopoulou, Evangelos Terpos, Meletios A Dimopoulos